Black Rock Inc. Bridge Bio Pharma, Inc. Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
A detailed history of Black Rock Inc. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 10,466,935 shares of BBIO stock, worth $265 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,466,935
Previous 10,156,773
3.05%
Holding current value
$265 Million
Previous $410 Million
21.07%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding BBIO
# of Institutions
284Shares Held
170MCall Options Held
7.41MPut Options Held
2.61M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY31.1MShares$787 Million40.56% of portfolio
-
Viking Global Investors LP25.1MShares$636 Million2.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$335 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$154 Million64.21% of portfolio
-
State Street Corp Boston, MA5.39MShares$137 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.76B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...